Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative clindamycin versus amoxicillin for prevention of early dental implant failure
ACTRN12624000324516Phase 3Not yet recruiting
- Sponsor
- Diego Pradillo Gallego
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of clindamycin and amoxicillin in Early dental implant failure (EDIF) (2 arms), sponsored by Diego Pradillo Gallego. Primary endpoint: Early dental implant failure. Planned start Jun 2024; status: not yet recruiting.
02
Drugs
clindamycinamoxicillin
03
Conditions
Early dental implant failure (EDIF)
Beyond the preview
Go deeper on ACTRN12624000324516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000324516.